BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 14747535)

  • 1. Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway.
    Fukuda M; Longnecker R
    J Virol; 2004 Feb; 78(4):1697-705. PubMed ID: 14747535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway.
    Swart R; Ruf IK; Sample J; Longnecker R
    J Virol; 2000 Nov; 74(22):10838-45. PubMed ID: 11044134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway.
    Fukuda M; Longnecker R
    J Virol; 2007 Sep; 81(17):9299-306. PubMed ID: 17582000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells.
    Morrison JA; Klingelhutz AJ; Raab-Traub N
    J Virol; 2003 Nov; 77(22):12276-84. PubMed ID: 14581564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways.
    Chen RH; Chang MC; Su YH; Tsai YT; Kuo ML
    J Biol Chem; 1999 Aug; 274(33):23013-9. PubMed ID: 10438468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells.
    Arvanitakis L; Yaseen N; Sharma S
    J Immunol; 1995 Aug; 155(3):1047-56. PubMed ID: 7636179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.
    Song K; Cornelius SC; Reiss M; Danielpour D
    J Biol Chem; 2003 Oct; 278(40):38342-51. PubMed ID: 12876289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt.
    Scholle F; Bendt KM; Raab-Traub N
    J Virol; 2000 Nov; 74(22):10681-9. PubMed ID: 11044112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
    Portis T; Longnecker R
    Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways.
    Zhu Y; Culmsee C; Klumpp S; Krieglstein J
    Neuroscience; 2004; 123(4):897-906. PubMed ID: 14751283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta1 modulates Fas (APO-1/CD95)-mediated apoptosis of human pre-B cell lines.
    Lanvin O; Guglielmi P; Fuentes V; Gouilleux-Gruart V; Mazière C; Bissac E; Regnier A; Benlagha K; Gouilleux F; Lassoued K
    Eur J Immunol; 2003 May; 33(5):1372-81. PubMed ID: 12731064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin and transforming growth factor-beta signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway.
    Bailey JP; Nieport KM; Herbst MP; Srivastava S; Serra RA; Horseman ND
    Mol Endocrinol; 2004 May; 18(5):1171-84. PubMed ID: 14963111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus latent membrane protein-2A induces ITAM/Syk- and Akt-dependent epithelial migration through αv-integrin membrane translocation.
    Fotheringham JA; Coalson NE; Raab-Traub N
    J Virol; 2012 Oct; 86(19):10308-20. PubMed ID: 22837212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to TGF-beta1 correlates with a reduction of TGF-beta type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines.
    Inman GJ; Allday MJ
    J Gen Virol; 2000 Jun; 81(Pt 6):1567-78. PubMed ID: 10811940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phosphatidylinositol 3-kinase/Akt pathway regulates transforming growth factor-{beta} signaling by destabilizing ski and inducing Smad7.
    Band AM; Björklund M; Laiho M
    J Biol Chem; 2009 Dec; 284(51):35441-9. PubMed ID: 19875456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LY294002-mediated inhibition of phosphatidylinositol 3-kinase activity triggers growth inhibition and apoptosis in CD40-triggered Ramos-Burkitt lymphoma B cells.
    Curnock AP; Knox KA
    Cell Immunol; 1998 Aug; 187(2):77-87. PubMed ID: 9732695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor.
    Horowitz JC; Lee DY; Waghray M; Keshamouni VG; Thomas PE; Zhang H; Cui Z; Thannickal VJ
    J Biol Chem; 2004 Jan; 279(2):1359-67. PubMed ID: 14576166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
    Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG
    Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta activates both pro-apoptotic and survival signals in fetal rat hepatocytes.
    Valdés F; Murillo MM; Valverde AM; Herrera B; Sánchez A; Benito M; Fernández M; Fabregat I
    Exp Cell Res; 2004 Jan; 292(1):209-18. PubMed ID: 14720520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways.
    Xiao GH; Jeffers M; Bellacosa A; Mitsuuchi Y; Vande Woude GF; Testa JR
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):247-52. PubMed ID: 11134526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.